Last updated: 28 June 2024 at 4:15pm EST

Scott Biller Net Worth




The estimated Net Worth of Scott Biller is at least $11 Million dollars as of 11 June 2019. Scott Biller owns over 7,218 units of Foghorn Therapeutics stock worth over $312,668 and over the last 11 years Scott sold FHTX stock worth over $10,699,357.

Scott Biller FHTX stock SEC Form 4 insiders trading

Scott has made over 69 trades of the Foghorn Therapeutics stock since 2014, according to the Form 4 filled with the SEC. Most recently Scott exercised 7,218 units of FHTX stock worth $16,890 on 11 June 2019.

The largest trade Scott's ever made was exercising 46,795 units of Foghorn Therapeutics stock on 6 December 2017 worth over $81,423. On average, Scott trades about 6,794 units every 23 days since 2014. As of 11 June 2019 Scott still owns at least 33,729 units of Foghorn Therapeutics stock.

You can see the complete history of Scott Biller stock trades at the bottom of the page.



What's Scott Biller's mailing address?

Scott's mailing address filed with the SEC is 500 TECHNOLOGY SQUARE, STE 700, CAMBRIDGE, MA, 02139.

Insiders trading at Foghorn Therapeutics

Over the last 4 years, insiders at Foghorn Therapeutics have traded over $262,160 worth of Foghorn Therapeutics stock and bought 305,500 units worth $4,888,000 . The most active insiders traders include Adam Koppel, Ian F Smith, and B Lynne Parshall. On average, Foghorn Therapeutics executives and independent directors trade stock every 109 days with the average trade being worth of $663,343. The most recent stock trade was executed by Steven F. Bellon on 9 September 2024, trading 20,000 units of FHTX stock currently worth $190,000.



What does Foghorn Therapeutics do?

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia; and FHD-609, a small molecule protein degrader of BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor and a protein degrader as selective modulators of BRM; and ARID1B selective modulators for the treatment of ovarian, endometrial, colorectal, bladder, and gastric cancers. Foghorn Therapeutics Inc. has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel therapeutics based on disruptors of a specified transcription factor target. The company was founded in 2015 and is headquartered in Cambridge, Massachusetts.



What does Foghorn Therapeutics's logo look like?

Foghorn Therapeutics Inc. logo

Complete history of Scott Biller stock trades at Agios Pharmaceuticals Inc and Foghorn Therapeutics

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
11 Jun 2019 Scott Biller
Chief Scientific Officer
Option 7,218 $2.34 $16,890
11 Jun 2019
33,729
5 Apr 2019 Scott Biller
Chief Scientific Officer
Option 3,000 $39.76 $119,280
5 Apr 2019
29,511
5 Mar 2019 Scott Biller
Chief Scientific Officer
Option 3,000 $38.60 $115,800
5 Mar 2019
29,511
27 Feb 2019 Scott Biller
Chief Scientific Officer
Option 9,000 $15.10 $135,900
27 Feb 2019
35,511
21 Dec 2018 Scott Biller
Chief Scientific Officer
Option 20,500 $2.34 $47,970
21 Dec 2018
24,637
5 Nov 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $9.05 $27,150
5 Nov 2018
53,932
5 Oct 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $9.05 $27,150
5 Oct 2018
53,932
5 Sep 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $9.05 $27,150
5 Sep 2018
60,196
6 Aug 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $9.05 $27,150
6 Aug 2018
60,196
5 Jul 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $9.05 $27,150
5 Jul 2018
60,196
5 Jun 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $9.05 $27,150
5 Jun 2018
60,196
23 May 2018 Scott Biller
Chief Scientific Officer
Option 15,177 $31.64 $480,200
23 May 2018
72,373
7 May 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $9.05 $27,150
7 May 2018
60,196
5 Apr 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $9.05 $27,150
5 Apr 2018
60,196
28 Mar 2018 Scott Biller
Chief Scientific Officer
Option 4,137 $2.32 $9,598
28 Mar 2018
57,196
5 Mar 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $9.05 $27,150
5 Mar 2018
56,059
5 Feb 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $8.87 $26,610
5 Feb 2018
56,059
10 Jan 2018 Scott Biller
Chief Scientific Officer
Option 3,000 $0.47 $1,410
10 Jan 2018
56,059
6 Dec 2017 Scott Biller
Chief Scientific Officer
Option 46,795 $1.74 $81,423
6 Dec 2017
53,059
1 Dec 2017 Scott Biller
Chief Scientific Officer
Option 2,146 $31.64 $67,899
1 Dec 2017
8,410
1 Nov 2017 Scott Biller
Chief Scientific Officer
Option 2,146 $31.64 $67,899
1 Nov 2017
8,410
4 Oct 2017 Scott Biller
Chief Scientific Officer
Sale 10,470 $70.00 $732,900
4 Oct 2017
0
2 Oct 2017 Scott Biller
Chief Scientific Officer
Option 2,146 $19.10 $40,989
2 Oct 2017
7,219
11 Sep 2017 Scott Biller
Chief Scientific Officer
Sale 15,000 $65.00 $975,000
11 Sep 2017
10,470
1 Sep 2017 Scott Biller
Chief Scientific Officer
Option 2,146 $9.05 $19,421
1 Sep 2017
8,410
1 Aug 2017 Scott Biller
Chief Scientific Officer
Sale 23,146 $59.60 $1,379,502
1 Aug 2017
25,470
7 Jul 2017 Scott Biller
Chief Scientific Officer
Option 2,146 $9.05 $19,421
7 Jul 2017
8,410
23 Jun 2017 Scott Biller
Chief Scientific Officer
Option 3,000 $0.47 $1,410
23 Jun 2017
6,264
21 Jun 2017 Scott Biller
Chief Scientific Officer
Option 7,292 $5.52 $40,252
21 Jun 2017
3,264
3 Apr 2017 Scott Biller
Chief Scientific Officer
Option 2,146 $9.05 $19,421
3 Apr 2017
17,880
20 Mar 2017 Scott Biller
Chief Scientific Officer
Option 6,438 $8.38 $53,950
20 Mar 2017
15,975
14 Nov 2016 Scott Biller
Chief Scientific Officer
Sale 32,500 $65.00 $2,112,500
14 Nov 2016
48,270
14 Nov 2016 Scott Biller
Chief Scientific Officer
Sale 32,500 $65.00 $2,112,500
14 Nov 2016
48,270
9 Nov 2016 Scott Biller
Chief Scientific Officer
Sale 5,000 $60.00 $300,000
9 Nov 2016
11,000
9 Nov 2016 Scott Biller
Chief Scientific Officer
Sale 5,000 $60.00 $300,000
9 Nov 2016
11,000
5 Oct 2016 Scott Biller
Chief Scientific Officer
Sale 5,000 $55.00 $275,000
5 Oct 2016
16,000
5 Oct 2016 Scott Biller
Chief Scientific Officer
Sale 5,000 $55.00 $275,000
5 Oct 2016
16,000
20 Sep 2016 Scott Biller
Chief Scientific Officer
Sale 5,000 $50.00 $250,000
20 Sep 2016
21,000
20 Sep 2016 Scott Biller
Chief Scientific Officer
Sale 5,000 $50.00 $250,000
20 Sep 2016
21,000
8 Jun 2016 Scott Biller
Chief Scientific Officer
Option 42,700 $4.26 $181,902
8 Jun 2016
74,270
3 Feb 2016 Scott Biller
Chief Scientific Officer
Option 10,000 $0.47 $4,700
3 Feb 2016
59,070
7 Jan 2016 Scott Biller
Chief Scientific Officer
Option 15,000 $0.47 $7,050
7 Jan 2016
49,070
31 Dec 2015 Scott Biller
Chief Scientific Officer
Option 5,500 $31.64 $174,020
31 Dec 2015
39,570
30 Nov 2015 Scott Biller
Chief Scientific Officer
Option 5,500 $31.64 $174,020
30 Nov 2015
39,570
2 Nov 2015 Scott Biller
Chief Scientific Officer
Option 5,500 $31.64 $174,020
2 Nov 2015
39,570
30 Sep 2015 Scott Biller
Chief Scientific Officer
Option 5,500 $31.64 $174,020
30 Sep 2015
39,570
10 Aug 2015 Scott Biller
Chief Scientific Officer
Option 5,500 $31.64 $174,020
10 Aug 2015
39,570
20 Jul 2015 Scott Biller
Chief Scientific Officer
Option 5,500 $31.64 $174,020
20 Jul 2015
39,570
26 Jun 2015 Scott Biller
Chief Scientific Officer
Option 7,500 $0.47 $3,525
26 Jun 2015
45,070
16 Jun 2015 Scott Biller
Chief Scientific Officer
Option 300 $0.47 $141
16 Jun 2015
37,570
8 Jun 2015 Scott Biller
Chief Scientific Officer
Sale 5,500 $121.85 $670,175
8 Jun 2015
37,270
8 Apr 2015 Scott Biller
Chief Scientific Officer
Sale 11,000 $96.98 $1,066,780
8 Apr 2015
34,070
16 Mar 2015 Scott Biller
Chief Scientific Officer
Option 5,500 $0.47 $2,585
16 Mar 2015
48,270
2 Jan 2015 Scott Biller
Chief Scientific Officer
Option 4,500 $0.47 $2,115
2 Jan 2015
47,000
1 Dec 2014 Scott Biller
Chief Scientific Officer
Option 4,500 $0.47 $2,115
1 Dec 2014
47,000
20 Nov 2014 Scott Biller
Chief Scientific Officer
Option 7,500 $0.47 $3,525
20 Nov 2014
42,500
3 Nov 2014 Scott Biller
Chief Scientific Officer
Option 4,500 $0.47 $2,115
3 Nov 2014
39,500
1 Oct 2014 Scott Biller
Chief Scientific Officer
Option 4,500 $0.47 $2,115
1 Oct 2014
39,500
19 Sep 2014 Scott Biller
Chief Scientific Officer
Option 37,996 $0.47 $17,858
19 Sep 2014
72,996
7 Aug 2014 Scott Biller
Chief Scientific Officer
Option 9,500 $0.47 $4,465
7 Aug 2014
39,500
1 Aug 2014 Scott Biller
Chief Scientific Officer
Option 4,500 $0.47 $2,115
1 Aug 2014
34,500
1 Jul 2014 Scott Biller
Chief Scientific Officer
Option 4,500 $0.47 $2,115
1 Jul 2014
34,500
20 Jun 2014 Scott Biller
Chief Scientific Officer
Option 2,004 $0.47 $942
20 Jun 2014
32,004
2 Jun 2014 Scott Biller
Chief Scientific Officer
Option 4,500 $0.47 $2,115
2 Jun 2014
34,500
1 May 2014 Scott Biller
Chief Scientific Officer
Option 4,500 $0.47 $2,115
1 May 2014
34,500
1 Apr 2014 Scott Biller
Chief Scientific Officer
Option 34,500 $0.47 $16,215
1 Apr 2014
34,500
3 Mar 2014 Scott Biller
Chief Scientific Officer
Option 6,000 $0.47 $2,820
3 Mar 2014
6,000
3 Feb 2014 Scott Biller
Chief Scientific Officer
Option 6,000 $0.47 $2,820
3 Feb 2014
6,000
21 Jan 2014 Scott Biller
Chief Scientific Officer
Option 6,000 $0.47 $2,820
21 Jan 2014
6,000


Foghorn Therapeutics executives and stock owners

Foghorn Therapeutics executives and other stock owners filed with the SEC include: